Ziopharm Oncology's Reverse Merger Round

Ziopharm Oncology raised a round of funding on September 16, 2005. Investors include EasyWeb.

ZIOPHARM is a biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of in-licensed cancer drugs to address unmet medical needs. The Company applies new insi…

Articles about Ziopharm Oncology's Reverse Merger Round: